The Quebec government will be offering a third dose of an mRNA vaccine to those that have received the Oxford-AstraZeneca vaccine that wish to travel.
This decision was made as many countries do not recognize the Oxford-AstraZeneca vaccine made at the Serum Institute of India, which will make travel difficult or not possible for many recipients.
To date, there have been no studies that have been made to evaluate the impact of receiving three COVID-19 vaccines.
According to the Montreal Gazette, “A spokesman for the Health Department said [...] a third dose doesn’t necessarily provide more protection compared with two doses, adding that the safety of receiving two shots of AstraZeneca mixed with an mRNA vaccine is unclear.”
The Quebec government is asking those that wish to receive the third dose to evaluate whether the risks of receiving the vaccine outweigh the desire to travel.
